NDC 50090-6765-01 - Glipizide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6765
- Requested NDC
- 50090-6765-01
- Package NDCs from labels
- 50090-6765-0, 50090-6765-1, 50090-6765-2, 50090-6765-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glipizide - A-S Medication Solutions | A-S Medication Solutions | 2023-10-23 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6765-0 | Glipizide | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 3 | |
| 50090-6765-1 | Glipizide | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 3 | |
| 50090-6765-2 | Glipizide | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6765 | GLIPIZIDE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 3 package rows | 20231024_08b01608-73c2-45e0-8de4-c6c401261152.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6765-1 | EA - Each | 50090-6765 | c48c82c0-5ac3-40c4-8571-c057bf2f2ccf | 1 | 2023-12-05 |
| 50090-6765-2 | EA - Each | 50090-6765 | ae47575e-25ab-4302-92ab-d34628484150 | 1 | 2023-12-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Lubricant Eye Drops Long Lasting | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Chain Drug Marketing Assoc., Inc. | 0cd91c45-88a2-f88c-e063-6294a90ad127 | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Archies Dry Eye Relief | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Archie's Remedies | 07da099b-6b7f-984d-e063-6294a90a12ac | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Equaline Multi-Symptom Eye Drops | POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | United Natural Foods, Inc. | fe467606-6d66-b695-e053-6294a90aab5d | 2025-12-30 | Warnings | B697894SGQ |
| Glipizide | GLIPIZIDE | Northwind Health Company, LLC | 0a1e1152-ade7-2092-e063-6394a90a99e7 | 2025-12-26 | Warnings, Adverse reactions | ANDA206928 314006 X7WDT95N5C |
| Glipizide | GLIPIZIDE | Northwind Health Company, LLC | 0effd04d-172c-5d8c-e063-6294a90a93f4 | 2025-12-26 | Warnings, Adverse reactions | ANDA206928 315107 X7WDT95N5C |
| Walgreens Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4538-2061-e063-6394a90a6e73 | 2025-12-19 | Warnings | 6DC9Q167V3 B697894SGQ |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | B697894SGQ |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | B697894SGQ |
| Glipizide and metformin hcl | GLIPIZIDE AND METFORMIN HCL | Chartwell RX, LLC | ac018f64-fd9d-4b3c-b0ac-ca305b8df635 | 2025-12-10 | Boxed warning, Adverse reactions | X7WDT95N5C |
| Snap Labs Ammonia Inhalants | AMMONIA INHALANT | Brined LLC d/b/a Snap Labs | 453b0e9c-8676-99fa-e063-6394a90a88a1 | 2025-12-08 | Warnings | 5138Q19F1X |
| Snap Labs 20-Count Ammonia Inhalants | AMMONIA INHALANTS | Brined LLC d/b/a Snap Labs | 4575d816-b08f-13fb-e063-6294a90af3ba | 2025-12-08 | Warnings | 5138Q19F1X |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 16fb8bc7-1db1-477e-a201-b3b678b8a84c | 2025-12-03 | Warnings, Adverse reactions | X7WDT95N5C |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 6DC9Q167V3 |
| Systane Complete PF | PROPYLENE GLYCOL EMULSION | Alcon Laboratories, Inc. | 798ffdde-1dba-4a3f-a0b6-937f9e958cca | 2025-11-03 | Warnings | 6DC9Q167V3 |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 3b111484-78ef-4db9-95ee-6cc4b6acdd59 | 2025-11-01 | Warnings, Adverse reactions | X7WDT95N5C |
| Glipizide | GLIPIZIDE | A-S Medication Solutions | 155216cf-4bad-479a-83b6-032d4bd11c2e | 2025-11-01 | Warnings, Adverse reactions | X7WDT95N5C |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | 6DC9Q167V3 |
| KINKAN | AMMONIA, CAMPHOR (NATURAL), MENTHOL | KINKANDO CO., LTD . | f2c0f3e1-792b-4798-bf6d-acd1bbefa261 | 2025-10-21 | Warnings | 5138Q19F1X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.